CAPNS2 |
Q96L46
|
calpain small subunit 2
|
|
1.9E-03 |
0.890 |
0.154 |
DISC2 |
|
disrupted in schizophrenia 2
|
|
|
0.716 |
0.192 |
RCL1 |
Q9Y2P8
|
RNA terminal phosphate cyclase like 1
|
Enzyme
|
5.9E-02 |
0.792 |
0.192 |
TSNAX |
Q99598
|
translin associated factor X
|
|
0.49 |
0.760 |
0.192 |
GALR3 |
O60755
|
galanin receptor 3
|
G-protein coupled receptor
|
1.3E-04 |
0.760 |
0.192 |
CYB561 |
P49447
|
cytochrome b561
|
Enzyme
|
0.61 |
0.780 |
0.192 |
MORC1 |
Q86VD1
|
MORC family CW-type zinc finger 1
|
|
5.9E-06 |
0.805 |
0.192 |
INO80C |
Q6PI98
|
INO80 complex subunit C
|
|
4.1E-04 |
0.805 |
0.192 |
NGEF |
Q8N5V2
|
neuronal guanine nucleotide exchange factor
|
|
0.66 |
0.861 |
0.192 |
SYT7 |
O43581
|
synaptotagmin 7
|
Transporter
|
0.96 |
0.686 |
0.231 |
HTR5A |
P47898
|
5-hydroxytryptamine receptor 5A
|
G-protein coupled receptor
|
6.3E-03 |
0.716 |
0.231 |
CPLX2 |
Q6PUV4
|
complexin 2
|
|
0.53 |
0.736 |
0.231 |
SORCS3 |
Q9UPU3
|
sortilin related VPS10 domain containing receptor 3
|
Transporter
|
3.7E-05 |
0.760 |
0.231 |
TAAR6 |
Q96RI8
|
trace amine associated receptor 6
|
G-protein coupled receptor
|
1.7E-02 |
0.780 |
0.231 |
CABP1 |
Q9NZU7
|
calcium binding protein 1
|
|
0.89 |
0.805 |
0.231 |
DEPDC7 |
Q96QD5
|
DEP domain containing 7
|
Nucleic acid binding
|
8.3E-11 |
0.805 |
0.231 |
APOF |
Q13790
|
apolipoprotein F
|
|
1.0E-02 |
0.805 |
0.231 |
PRD |
|
primary retinal dysplasia
|
|
|
0.821 |
0.231 |
DAZAP2 |
Q15038
|
DAZ associated protein 2
|
|
0.36 |
0.890 |
0.231 |
KREMEN2 |
Q8NCW0
|
kringle containing transmembrane protein 2
|
Receptor
|
3.7E-05 |
0.861 |
0.231 |
SLC4A10 |
Q6U841
|
solute carrier family 4 member 10
|
Transporter
|
0.13 |
0.678 |
0.269 |
SV2A |
Q7L0J3
|
synaptic vesicle glycoprotein 2A
|
Transporter
|
0.23 |
0.722 |
0.269 |
NLGN2 |
Q8NFZ4
|
neuroligin 2
|
|
1.00 |
0.722 |
0.269 |
M6PR |
P20645
|
mannose-6-phosphate receptor, cation dependent
|
Receptor
|
9.2E-03 |
0.716 |
0.269 |
RNF123 |
Q5XPI4
|
ring finger protein 123
|
|
8.5E-05 |
0.736 |
0.269 |